News Focus
News Focus
Followers 416
Posts 15749
Boards Moderated 1
Alias Born 10/08/2009

Re: None

Monday, 10/20/2025 9:00:08 AM

Monday, October 20, 2025 9:00:08 AM

Post# of 78
IOBT nice news out this morning .. IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025

https://investorshub.advfn.com/stock-market/NASDAQ/io-biotech-IOBT/stock-news/97037525/io-biotech-presents-phase-3-results-for-cylembio
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOBT News